These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3644127)

  • 21. Safeguarding the blood supply by providing opportunities for anonymous HIV testing.
    Snyder AJ; Vergeront JM
    N Engl J Med; 1988 Aug; 319(6):374-5. PubMed ID: 3164832
    [No Abstract]   [Full Text] [Related]  

  • 22. HTLV-I in HIV seropositive Indian blood donors.
    Malhotra VL; Lakshmy A
    J Commun Dis; 1996 Dec; 28(4):270-2. PubMed ID: 9057451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of anti-HTLV III: modification of a commercial enzyme immunoassay.
    Barr A; Muir W; Dow BC; Arnott J; Macvarish IP
    Med Lab Sci; 1987 Jan; 44(1):97-9. PubMed ID: 3309535
    [No Abstract]   [Full Text] [Related]  

  • 24. [HIV antibodies: test methods in the group trial].
    Kühnl P; Seidl S
    Beitr Infusionther Klin Ernahr; 1987; 18():13-6. PubMed ID: 3326583
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of antibodies to HTLV in blood donors in north London.
    Barbara J; Moore MC; Hewitt PE
    BMJ; 2000 Mar; 320(7235):650. PubMed ID: 10698901
    [No Abstract]   [Full Text] [Related]  

  • 26. Computerised anti-HTLV-III data collection and integration.
    Houston SR; Barr A
    Med Lab Sci; 1986 Oct; 43(4):340-3. PubMed ID: 3477676
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevalence of antibodies against human immunodeficiency virus in prisoners and employees of penal institutions].
    Kindelán J; Jurado R; Aparicio A; Cantero P; Sánchez Guijo P
    Rev Clin Esp; 1987 Dec; 181(9):539. PubMed ID: 3482330
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparative evaluation of prevalence of HTLV-1 antibodies in blood donors in Delhi India by PAT and LIA method.
    Singh R; Thomas R
    J Commun Dis; 2003 Dec; 35(4):263-5. PubMed ID: 15909754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HIV in homosexuals in Barcelona: epidemiology and prevalence].
    Argelagués E; Muga R; Juncà J; Tor J; Bou D; Armengol P; Millà F; Ribas Mundó M; Capdevila JM
    Med Clin (Barc); 1987 Apr; 88(13):535-7. PubMed ID: 3647195
    [No Abstract]   [Full Text] [Related]  

  • 30. [Visceral leishmaniasis associated with positive anti-HTLV III antibody].
    Verdejo J; Alvar J; Polo RM; González Lahoz JM
    Rev Clin Esp; 1987 Mar; 180(4):221. PubMed ID: 3647541
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-HTLV-III antibodies in dialyzed or transplanted patients in Spain.
    Teixidó J; Argelagués E; Caralps A; Romero R; Oppenheimer F; Ricart MJ; Martorell J; Griñó JM; Solá R
    Nephron; 1987; 46(3):325-6. PubMed ID: 3306418
    [No Abstract]   [Full Text] [Related]  

  • 32. HTLV-III antibodies in a patient with mycosis fungoides.
    Srivastava BI; Getchell JP; Stoll HL
    J Med; 1986; 17(1):57-63. PubMed ID: 3473157
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of human immunodeficiency virus antibodies in inmates and officials of penitentiaries].
    Velardo A; Pineda JA; Leal M; Lissen E
    Rev Clin Esp; 1987 Mar; 180(4):224-5. PubMed ID: 3647542
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic abnormalities and antibodies to HTLV-III in asymptomatic drug addicts.
    Ortona L; Laghi V; Tamburrini E; Nervo P; Cauda R
    Ala J Med Sci; 1987 Jan; 24(1):46-51. PubMed ID: 3644604
    [No Abstract]   [Full Text] [Related]  

  • 38. [The prevalence of hepatitis C antibodies among volunteer blood donors with elevated blood transaminase and antibodies to the B virus core antigen].
    Gavilán Carrasco JC; González Santos P; Rosario Díaz E
    Rev Clin Esp; 1996 May; 196(5):277-80. PubMed ID: 8768025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico].
    Ayala Gaytán JJ; Guerra Avalos FJ; Mora Brondo P; Casillas Romo A
    Rev Gastroenterol Mex; 1997; 62(4):250-3. PubMed ID: 9528294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.
    Ranki A; Weiss SH; Valle SL; Antonen J; Krohn KJ
    Clin Exp Immunol; 1987 Aug; 69(2):231-9. PubMed ID: 3652531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.